CenTrial Logo

Impact of Repetitive Transcranial Magnetic Stimulation on Alzheimer's Disease


Clinical trial finds that both active rTMS and sham treatment improved cognition in Alzheimer's patients

Alzheimer's disease is a complex neurological condition that affects millions of people worldwide. Scientists are constantly searching for new ways to tackle its challenges and improve the lives of those affected. One avenue of research gaining attention is repetitive transcranial magnetic stimulation (rTMS), a non-invasive procedure that may hold the potential for easing Alzheimer's symptoms.

Clinical Trial

A clinical trial aimed to investigate the effectiveness of rTMS in individuals with mild to moderate Alzheimer's disease. The trial asked several important questions:

  1. Does active rTMS treatment offer real benefits compared to a sham treatment?
  2. How does the duration of treatment (2 or 4 weeks) affect outcomes?
  3. How long do the benefits of treatment last?

The trial was conducted at multiple sites and used a double-blind randomized approach to ensure fairness and accuracy. Patients were divided into groups receiving either active rTMS or a sham treatment, with consideration given to factors like age and disease severity. rTMS pulses were directed to specific parts of the brain using advanced navigation techniques.

Key Findings

Analysis of data from 135 patients revealed something unexpected: both active rTMS and sham treatments led to significant improvements in cognitive function. These improvements lasted for up to two months after treatment. This surprising result suggests that even the sham treatment, which doesn't deliver the intended magnetic pulses, may have some positive effects on the brain.


These findings are exciting because they suggest that rTMS could be a useful tool in managing Alzheimer's symptoms. However, more research is needed to understand why the sham treatment also had benefits. Future studies could explore the underlying reasons for this and fine-tune treatment approaches to maximize effectiveness.


While Alzheimer's disease presents significant challenges, research into treatments like rTMS offers hope for better outcomes. This trial provides valuable insights into the potential of rTMS to improve cognitive function in Alzheimer's patients. As scientists continue to unravel the mysteries of the brain, there is optimism that new treatments will emerge to help those affected by this devastating condition.

Share this article with a friend:

Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

20,000 clinical trials are seeking participants.
Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.